Products for Research Use Only

Epcoritamab (Anti-CD20 & CD3)

CAT: 0957-A4008Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0957-A4008Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Epcoritamab is a bispecific IgG1 antibody that targets CD3 and CD20, exhibiting strong T-cell-mediated cytotoxic activity against CD20+ malignant B cells. It is used in the treatment of adults in relapsed or refractory (R/R) large B-cell lymphoma (LBCL), including diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma after ≥2 lines of systemic treatment. MW: 145.26 KD.
CAS Number
948564-73-6
Synonyms
GEN3013, DuoBody-CD3xCD20
Target
CD markers
Activity
Transmembrane Transporters
Storage Conditions
-80°C (avoid freeze-thaw cycles)